Novel personalized cancer vaccine platform based on Bacillus Calmette-Guerin
E. Ylosmaki, B. Martins, M. Fusciello, S. Feola, F. Hamdan, J. Chiaro, L. Ylosmaki, M. J. Vaughan, T. Viitala, P. S. Kulkarni, V. Cerullo
This paper develops a BCG-based cancer vaccine platform that enhances anti-tumor immune responses by attaching tumor-specific peptides to BCG, improving therapeutic outcomes in mouse models.
bioRxiv · Mar 5, 2021Cancer Biology